CoChat

Performance of point-of-care HbA 1c test devices: implications for use in clinical practice – a systematic review and meta-analysis

Open access
Hirst, Jennifer A., McLellan, Julie H., Price, Christopher P., English, Emma, Feakins, Benjamin G., Stevens, Richard J., Farmer, Andrew J. · 2017 · Clinical Chemistry and Laboratory Medicine (CCLM)

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Abstract

Background: Point-of-care (POC) devices could be used to measure hemoglobin A 1c (HbA 1c ) in the doctors’ office, allowing immediate feedback of results to patients. Reports have raised concerns about the analytical performance of some of these devices. We carried out a systematic review and meta-analysis using a novel approach to compare the accuracy and precision of POC HbA 1c devices. Methods: Medline, Embase and Web of Science databases were searched in June 2015 for published reports comparing POC HbA 1c devices with laboratory methods. Two reviewers screened articles and extracted data on bias, precision and diagnostic accuracy. Mean bias and variability between the POC and laboratory test were combined in a meta-analysis. Study quality was assessed using the QUADAS2 tool. Results: Two researchers independently reviewed 1739 records for eligibility. Sixty-one studies were included in the meta-analysis of mean bias. Devices evaluated were A1cgear, A1cNow, Afinion, B-analyst, Clover, Cobas b101, DCA 2000/Vantage, HemoCue, Innovastar, Nycocard, Quo-Lab, Quo-Test and SDA1cCare. Nine devices had a negative mean bias which was significant for three devices. There was substantial variability in bias within devices. There was no difference in bias between clinical or laboratory operators in two devices. Conclusions: This is the first meta-analysis to directly compare performance of POC HbA 1c devices. Use of a device with a mean negative bias compared to a laboratory method may lead to higher levels of glycemia and a lower risk of hypoglycaemia. The implications of this on clinical decision-making and patient outcomes now need to be tested in a randomized trial.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1515/cclm-2016-0303

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY-NC-ND · From the PDF
Figure 2 Forest plot showing mean bias (in % HbA 1c ) and 95% CI and prediction intervals, by POC device, ordered by mean bias.
Figure 2 Forest plot showing mean bias (in % HbA 1c ) and 95% CI and prediction intervals, by POC device, ordered by mean bias.CC-BY-NC-ND · From the PDF
Figure 3 Forest plot showing standard deviation of differences, 95% confidence intervals of SD and prediction intervals for included studies, by POC device, ordered by SD.
Figure 3 Forest plot showing standard deviation of differences, 95% confidence intervals of SD and prediction intervals for included studies, by POC device, ordered by SD.CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Research works printed but not linked: 10

  1. Wood JA, Kaminski BM, Kollman C, Diabetes P. The accuracy and precision of the axis-shield afinion HbA1c measure ment device. Diabetes 2011; Conference: 71st Scientific Sessions of the American Diabetes Association San Diego, CA United States. Conference Start: 20110624 Conference End: 20110628. Conference Publication: (var.pagings). 60:A237.
  2. Health Quality Ontario. Point-of-care hemoglobin A1c testing: an evidence-based analysis. Ont Health Technol Assess Ser 2014;14:1–30.
  3. Clark AL, Irvin BR, Isbell AW, Ammirati EA. Multi-site correlation of A1cNow %A1C assay to a standardized laboratory. Clin Chem 2005;51:A259–A.
  4. Estevez Fidalgo P, Pineiro Caamano A, Otero Santiago M, Garcia Aschauer JM, Lorenzo Freire MT, Espana Barrada R, et al. Validation of HbA1c results obtained with a point of care instrument. Clin Chem Lab Med 2014;52:S1523.
  5. Harris S, Tokmakejian S, Edmonds M, Webster-Bogaert S, Mahon J, Porter S, et al. Validation of the bayer DCA2000 (TM) as a point-of-care measure of glycosylated haemoglobin. Diabetes 2000;49:A110–A.
  6. Heng PY, Fun S, Chui KL, Taufik MA, Lew MY, Wong MS. An evaluation of the performance of Roche Cobas b101 point-of-care system in the measurement of haemoglobin A1C. Clin Chem Lab Med 2015;53:S623.
  7. Jou JM, Bedini JL, Seuma J, Luna N, Kinder M. Evaluati on of the point of care a1cnow+ analy zer for HBA1C. International Journal of Laboratory Hematology 2013; Conference: 26th International Symposium on Technological Innovations in Laboratory Hematology, ISLH 2013 Toronto, ON Canada. Conference Start: 20130510 Conference End: 20130512. Conference Publication: (var.pagings). 35:50.
  8. Rossi L, Della Bartola L, Giampietro O, Consani C, Pellegrini G, Matteucci E. Point-of-care hbA1c testing in a clinical setting: performance analysis. Clin Chem Lab Med 2015;53:S543.
  9. Thueringer JT, Ishani A, Rector T, Greer N, Ercan-Fang N. Comparison of a1c measurements from a home test device to a hospital laboratory. Diabetes 2012; Conference: 72nd Scientific Sessions of the American Diabetes Association Philadelphia, PA, United States. Conference Start: 20120608 Conference End: 20120612. Conference Publication: (var.pagings). 61:A218.
  10. Williams PF, Tan K, Sherfan J, Woolnough C, Lin E, Brown M, et al. Comparison of three point of care (POC) HbA1c devices with cation exchange and capillary electrophoresis. Diabetes 2014;63:A220.

Cited by

See all 103

Metadata

Authors
Hirst, J. A., McLellan, J. H., Price, C. P., English, E., Feakins, B. G., Stevens, R. J., & Farmer, A. J.
Affiliations
  • University of Oxford (GB)
  • University of East Anglia (GB)
  • University of Oxford, Nuffield Department of Primary Care Health Sciences, United Kingdom of Great Britain and Northern Ireland
Corresponding author
Hirst, Jennifer A.
Venue
Clinical Chemistry and Laboratory Medicine (CCLM)
Published
2016-09-22
Volume
55
Issue
2
Pages
167-180
ISSN
  • 1434-6621 (ISSN-L)
  • 1437-4331
OpenAlex
W2522836126
Cited by
102
References
68
Citations by year
2026: 11 · 2025: 7 · 2024: 7 · 2023: 11 · 2022: 17 · 2021: 15 · 2020: 7 · 2019: 9 · 2018: 11 · 2017: 5 · 2016: 2
FWCI
1.06
Type
journal article
Language
en
Open access
Locations
  • Clinical Chemistry and Laboratory Medicine (CCLM) (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • UEA Digital Repository (University of East Anglia) (acceptedVersion)
Funders
National Institute for Health and Care Research (DRF-2013-06-086, NF-SI-0512-10077)
Topics
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
Keywords
point-of-care testing, HbA1c, device accuracy, measurement bias, precision, diabetes management, hypoglycemia risk, HemoCue
MeSH terms
Glycated Hemoglobin, Humans, Practice Guidelines as Topic, Point-of-Care Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Performance of point-of-care HbA 1c test devices: implications for use in clinical practice – a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1515/cclm-2016-0303
The paper
Hirst, J. A., McLellan, J. H., Price, C. P., English, E., Feakins, B. G., Stevens, R. J., & Farmer, A. J. (2017). Performance of point-of-care HbA 1c test devices: implications for use in clinical practice – a systematic review and meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM). https://doi.org/10.1515/cclm-2016-0303

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.